Our group found that inhibition of the tyrosine phosphatase, SHP-2, increased gene and cell surface protein expression of PD-L1 in KRAS-active NSCLC cell lines (manuscript submitted). This evidence concerns the gene PTPN11 and non-small cell lung carcinoma.